Industry, innovation and social values.
Remaining important tasks in finding and developing new drugs and vaccines for HIV/AIDS, malaria, cancer and other diseases require continued industry research and development. Industry's research and development pipeline has produced drugs that have saved AIDS victims previously facing certain death, but still no cure nor vaccine is yet available. Experience with the process of research and development indicates that it requires more than a decade of development to produce a new drug with costs in the hundreds of millions of dollars. Intellectual property protection is critically important in assuring that drug development continues. Partnerships between industry and the public sector have increased access to new therapies in developing countries and promise to enhance access to both patented and generic medicines in the future.
Bale
Harvey E
HE
International Federation of Pharmaceutical Manufacturers Association, 30 Rue de St-Jean, Geneva 1211, Switzerland. h.bale@ifpma.org
D002626:Chemistry, Pharmaceutical; D003906:Developing Countries; D004345:Drug Industry; D014943:Global Health; D012106:Research
Bull World Health Organ. 2000;78(4):549-61
10885184
Nature. 2002 Feb 7;415(6872):686-93
11832957
Curr Opin Pharmacol. 2001 Oct;1(5):504-10
11764777
Lancet Infect Dis. 2003 Jan;3(1):47-51
12505035
Lancet Infect Dis. 2001 Oct;1(3):199-202
11871496
J Health Econ. 1991 Jul;10(2):107-42
10113009
Lancet. 2003 Oct 18;362(9392):1267-74
14575971
BMJ. 1996 Jun 15;312(7045):1521-5
8646147
Bus Ethics Q. 2005 Oct;15(4):577-94
16358443
Emerg Infect Dis. 1995 Jan-Mar;1(1):1-6
8903147
Health Aff (Millwood). 2004 May-Jun;23(3):155-66
15160813
Thorax. 1995 Sep;50 Suppl 1:S37-42
7570462
J Health Econ. 2003 Mar;22(2):151-85
12606142
Am J Ther. 2002 Nov-Dec;9(6):543-55
12424516